22nd Century Group selling hemp operations for $2.25 million
Biotech company 22nd Century Group is selling off its hemp operations in a deal worth $2.25 million as part of an attempt to cut costs.
New York Medical Marijuana News
Biotech company 22nd Century Group is selling off its hemp operations in a deal worth $2.25 million as part of an attempt to cut costs.
Pete Sahani will succeed Arnaud Dumas de Rauly as CEO of The Blinc Group, a New York-City based cannabis vape maker, effective Dec. 1.
New York regulators on Monday approved settlement agreements in two lawsuits that have contributed to the tortuous rollout of legal adult-use cannabis sales in the state.
New York regulators delayed discussions to settle two marijuana licensing lawsuits, adding more uncertainty for social equity applicants in the state.
One of the most important opportunities to curb the illicit market is the integration of the marijuana industry into the banking system.
California cannabis brand Dosist has been acquired by longtime Los Angeles partner Final Bell Holdings International.
New York regulators and a group of disabled military veterans who challenged the state’s adult-use marijuana licensing process have reached “an agreement in principle to settle this matter,” according to court documents obtained by MJBizDaily.